Is dark chocolate or cocoa good for your heart?

Numbers match the citations in the article. A working link isn't proof that a page supports a claim; check the quoted passage and date.

1. 1

   Impact of cocoa flavanols on blood pressure and vascular function: an updated systematic review and meta-analysis of randomized controlled trials.

   The journal of nutrition, health & aging (Sakuda et al.)Published Sep 1, 2026Checked Oct 4, 2026

   “Both SBP and DBP decreased significantly following cocoa flavanol intake (SBP: MD -2.734 mmHg, 95% CI [-3.446, -2.023]; DBP: MD -1.848 mmHg, 95% CI [-2.725, -0.971]). Significant improvements were also observed for FMD (MD 1.314%, 95% CI [1.043, 1.585]) and PWV (MD -0.200 m/s, 95% CI [-0.393, -0.007]), whereas ABI showed no significant change, with limited evidence from only two studies. Subgroup analyses were consistent for SBP/DBP in both hypertensive and normotensive participants. Dose-response analyses revealed a significant inverse association between SBP or DBP and flavanol intake, but did not identify clear dose thresholds within the examined intake range. Certainty was moderate for SBP; other outcomes were limited.ConclusionThese findings suggest that cocoa flavanol intake of 10.6-1,680 mg/day may modestly reduce blood pressure and may improve selected vascular function indices, although certainty for vascular outcomes remains limited.”

2. 2

   The effects of cocoa products in individuals with metabolic syndrome and related diseases: a systematic review and meta-analysis.

   Journal of diabetes and metabolic disorders (Gomes et al.)Published Mar 17, 2026Checked Oct 4, 2026

   “Subgroup analyses and meta-regression were performed to identify the source of heterogeneity, and study quality assessment was conducted using the GRADE approach. A total of 13 RCTs, including 16 arms, that investigated the effects of cocoa on parameters related to metabolic syndrome were included. The meta-analysis showed a significant effect of cocoa supplementation on triacylglycerol levels (-0.21 mmol/L, 95% CI: -0.40, -0.02; p = 0.0333), and subgroup analysis suggested that cholesterol levels were reduced with cocoa supplementation in patients with dyslipidemia and diabetes. Furthermore, the meta-regression analysis suggested a decrease in glycemic and lipid profiles, as well as anthropometric parameters, in studies with longer durations of cocoa supplementation. Our study suggests that cocoa intake has limited evidence of benefit, mainly for triglycerides, furthermore, effects and that the duration, type, and clinical status of patients were important determinants for favorable effects on biomarkers related to metabolic syndrome.Supplementary informationThe online version contains supplementary material available at 10.1007/s40200-026-01914-7.”

3. 3

   Beyond Taste: The Impact of Chocolate on Cardiovascular and Steatotic Liver Disease Risk Factors.

   Nutrients (Tomaru et al.)Published Feb 14, 2026Checked Oct 4, 2026

   “Evidence from clinical studies suggests that chocolate modulates nitric oxide bioavailability and NADPH oxidase activity. Clinical findings demonstrate improvements in flow-mediated dilation, decreased NT-proBNP, reduced intestinal permeability and endotoxemia, improved lipid profile (increased HDL-c and reduced total cholesterol, LDL-c, and triglycerides), increased plasma polyphenols, improved platelet function, and attenuated hepatocyte apoptosis. These findings suggest a potential role for cocoa flavanol-rich dark chocolate in cardiometabolic health; however, the evidence remains preliminary and is limited by heterogeneous study designs, small sample sizes, and short intervention durations. Despite these limitations, current evidence supports the inclusion of moderate dark chocolate consumption as a possible adjunct strategy to mitigate cardiometabolic and hepatic metabolic risks. Further large-scale, long-term trials are needed to confirm these beneficial effects and to standardize the dosage and formulation of cocoa flavanols.”

4. 4

   Cardiovascular Protective Effects and Mechanisms of Action of Cacao: A Comprehensive Review.

   Reviews in cardiovascular medicine (Lee et al.)Published Feb 3, 2026Checked Oct 4, 2026

   “Notably, cacao is particularly effective in preventing cardiovascular diseases (CVDs) by regulating various biomarkers and signaling pathways. The functionality of cacao has been reported in multiple in vitro and in vivo studies and clinical trials, thereby further confirming its efficacy. However, comprehensive reviews on the recently reported preventive effects of cacao on CVDs and the related mechanisms in vitro, in vivo, and in clinical trials remain limited. Thus, this review aimed to provide an overview of the latest research results on the effects of cacao on the prevention of CVDs and on biomarkers associated with these mechanisms. Cacao shows significant potential to prevent and mitigate CVDs, with promising findings that could shape the future of cardiovascular health and functional plant innovation. However, to fully harness the potential of cacao, future research must focus on standardizing bioactive compound content, assessing bioavailability and metabolic pathways, and establishing dose-response relationships across diverse populations.”

5. 5

   Cocoa bean (Wikipedia)

   WikipediaPublished Oct 2, 2026Checked Oct 4, 2026

   “The cocoa bean, also known as cocoa () or cacao (), is the dried and fully fermented seed of Theobroma cacao, the cacao tree. Due to its high fat content, the bean can be ground into a liquor, from which cocoa butter and cocoa powder are extracted. Cacao trees are native to the Amazon rainforest. They are the basis of chocolate and Mesoamerican foods including tejate, an indigenous Mexican drink. The cacao tree was first domesticated at least 5,300 years ago by the Mayo-Chinchipe culture in South America before it was introduced in Mesoamerica. Cacao was consumed by pre-Hispanic cultures in spiritual ceremonies, and its beans were a common currency in Mesoamerica. The cacao tree grows in a limited geographical zone; today, West Africa produces nearly 81% of the world's crop. The three main varieties of cocoa plants are Forastero, Criollo, and Trinitario, with Forastero being the most widely used. In 2024, global cocoa bean production reached 5.8 million tonnes, with Ivory Coast leading at 38% of the total, followed by Ghana and Indonesia.”

6. 6

   Associations Between Chocolate Consumption and Cardiometabolic Risk Markers Across Metabolic Profiles: Insights from a Population-Based Study.

   Nutrients (Martín-Carro et al.)Published Sep 16, 2026Checked Oct 4, 2026

   “Overall, 30.1% of participants reported habitual chocolate consumption. In multivariable models without interaction terms, both dark and milk chocolate consumption were associated with lower BMI, whereas dark chocolate consumption was associated with higher LDL cholesterol. After Bonferroni correction for multiple comparisons, diabetes modified the associations of dark chocolate consumption with fasting glucose and HbA1c and of milk chocolate consumption with HbA1c. Among individuals with diabetes, dark chocolate consumption was associated with lower fasting glucose and HbA1c, whereas milk chocolate consumption was associated with lower HbA1c compared with non-consumption. No such associations were observed among individuals without diabetes. These findings suggest that the association between chocolate consumption and cardiometabolic health is not uniform across the population but differs according to the underlying metabolic profile. In particular, the associations with glycaemic markers were confined to individuals with diabetes, suggesting that metabolic status may modify the relationship between habitual chocolate consumption and glycaemic control.”